Browsing by Author "Carroll, Clinton J."

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Detection of prohibited treatment products on racing tires using headspace solid phase microextraction (SPME) and gas chromatography/ mass spectrometry (GC/MS)
    (Royal Society of Chemistry, 2016-01) Kranz, William D.; Carroll, Clinton J.; Goodpaster, John V.; Department of Chemistry & Chemical Biology, School of Science
    A variety of commercial tire treatments are available that purport to help automobile tires better cling to the surface of a road or racetrack, raising concerns in the professional racing community that such products might be used to illicitly boost performance in competitive events. These tire treatments are reputed to cut lap times and improve handling and maneuverability. In some cases, the manufacturers even boast that their products are “undetectable” (i.e., impervious to the scrutiny of laboratory testing). In this study, a number of banned tire treatment products were evaluated principally by gas chromatography-mass spectrometry (GC-MS) using solid phase microextraction (SPME) as a pre-concentration technique. The chemicals off-gassed by each product were determined and grouped into two broad categories: ‘plasticizer-based’ tire treatment products and ‘hydrocarbon-based’ tire treatment products. This information was then applied to the analysis of genuine tire samples provided by the United States Auto Club (USAC), a professional racing association. Over the course of one year, 10 out of the 71 questioned samples tested positive for a prohibited treatment product. The manufacturers' claims regarding their products' invisibility to lab tests were largely proven to be unfounded: both the products themselves and the tires treated with them can be identified by a number of characteristic volatile compounds. These included known plasticizers such as pentanedioic acid diethyl ester, plasticizer-related compounds such as 2-ethyl-1-hexanol, and dearomatized distillates.
  • Thumbnail Image
    Item
    Endothelial disruptive proinflammatory effects of nicotine and e-cigarette vapor exposures
    (American Physiological Society, 2015-07-15) Schweitzer, Kelly S.; Chen, Steven X.; Law, Sarah; Van Demark, Mary; Poirier, Christophe; Justice, Matthew J.; Hubbard, Walter C.; Kim, Elena S.; Lai, Xianyin; Wang, Mu; Kranz, William D.; Carroll, Clinton J.; Ray, Bruce D.; Bittman, Robert; Goodpaster, John V.; Petrache, Irina; Department of Biochemistry & Molecular Biology, IU School of Medicine
    The increased use of inhaled nicotine via e-cigarettes has unknown risks to lung health. Having previously shown that cigarette smoke (CS) extract disrupts the lung microvasculature barrier function by endothelial cell activation and cytoskeletal rearrangement, we investigated the contribution of nicotine in CS or e-cigarettes (e-Cig) to lung endothelial injury. Primary lung microvascular endothelial cells were exposed to nicotine, e-Cig solution, or condensed e-Cig vapor (1-20 mM nicotine) or to nicotine-free CS extract or e-Cig solutions. Compared with nicotine-containing extract, nicotine free-CS extract (10-20%) caused significantly less endothelial permeability as measured with electric cell-substrate impedance sensing. Nicotine exposures triggered dose-dependent loss of endothelial barrier in cultured cell monolayers and rapidly increased lung inflammation and oxidative stress in mice. The endothelial barrier disruptive effects were associated with increased intracellular ceramides, p38 MAPK activation, and myosin light chain (MLC) phosphorylation, and was critically mediated by Rho-activated kinase via inhibition of MLC-phosphatase unit MYPT1. Although nicotine at sufficient concentrations to cause endothelial barrier loss did not trigger cell necrosis, it markedly inhibited cell proliferation. Augmentation of sphingosine-1-phosphate (S1P) signaling via S1P1 improved both endothelial cell proliferation and barrier function during nicotine exposures. Nicotine-independent effects of e-Cig solutions were noted, which may be attributable to acrolein, detected along with propylene glycol, glycerol, and nicotine by NMR, mass spectrometry, and gas chromatography, in both e-Cig solutions and vapor. These results suggest that soluble components of e-Cig, including nicotine, cause dose-dependent loss of lung endothelial barrier function, which is associated with oxidative stress and brisk inflammation.